A detailed history of Jacobs Levy Equity Management, Inc transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,524,076 shares of CTMX stock, worth $1.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,524,076
Previous 1,507,717 1.09%
Holding current value
$1.52 Million
Previous $1.84 Million 2.23%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.12 - $1.51 $18,322 - $24,702
16,359 Added 1.09%
1,524,076 $1.8 Million
Q2 2024

Aug 14, 2024

BUY
$1.21 - $5.13 $1.18 Million - $5.02 Million
977,782 Added 184.51%
1,507,717 $1.84 Million
Q1 2024

May 15, 2024

SELL
$1.41 - $2.74 $368,695 - $716,471
-261,486 Reduced 33.04%
529,935 $1.16 Million
Q4 2023

Feb 14, 2024

SELL
$1.07 - $1.55 $278,931 - $404,060
-260,684 Reduced 24.78%
791,421 $1.23 Million
Q3 2023

Nov 16, 2023

SELL
$1.26 - $1.87 $717,323 - $1.06 Million
-569,304 Reduced 35.11%
1,052,105 $1.36 Million
Q2 2023

Aug 14, 2023

SELL
$1.41 - $1.92 $380,667 - $518,355
-269,977 Reduced 14.27%
1,621,409 $2.79 Million
Q1 2023

May 15, 2023

BUY
$1.48 - $2.88 $1.82 Million - $3.54 Million
1,229,494 Added 185.75%
1,891,386 $2.86 Million
Q4 2022

Feb 14, 2023

SELL
$1.19 - $1.91 $514,586 - $825,933
-432,426 Reduced 39.52%
661,892 $1.06 Million
Q3 2022

Nov 15, 2022

BUY
$1.23 - $1.97 $243,378 - $389,801
197,869 Added 22.07%
1,094,318 $1.59 Million
Q2 2022

Aug 15, 2022

SELL
$1.53 - $2.89 $273,351 - $516,330
-178,661 Reduced 16.62%
896,449 $1.64 Million
Q1 2022

May 16, 2022

SELL
$2.67 - $4.68 $437,348 - $766,588
-163,801 Reduced 13.22%
1,075,110 $2.87 Million
Q4 2021

Feb 14, 2022

SELL
$3.87 - $7.39 $600,465 - $1.15 Million
-155,159 Reduced 11.13%
1,238,911 $5.36 Million
Q3 2021

Nov 15, 2021

SELL
$4.32 - $6.43 $85,523 - $127,294
-19,797 Reduced 1.4%
1,394,070 $7.1 Million
Q2 2021

Aug 16, 2021

BUY
$6.33 - $9.91 $5.17 Million - $8.09 Million
816,469 Added 136.67%
1,413,867 $8.95 Million
Q1 2021

May 17, 2021

SELL
$6.6 - $9.0 $45,025 - $61,398
-6,822 Reduced 1.13%
597,398 $4.62 Million
Q4 2020

Feb 16, 2021

SELL
$6.47 - $7.9 $67,947 - $82,965
-10,502 Reduced 1.71%
604,220 $3.96 Million
Q3 2020

Nov 16, 2020

BUY
$6.55 - $8.83 $1.25 Million - $1.69 Million
191,180 Added 45.14%
614,722 $4.09 Million
Q2 2020

Aug 17, 2020

BUY
$7.4 - $14.64 $1.34 Million - $2.64 Million
180,530 Added 74.29%
423,542 $3.53 Million
Q1 2020

May 15, 2020

BUY
$3.61 - $8.6 $79,250 - $188,795
21,953 Added 9.93%
243,012 $1.86 Million
Q4 2019

Feb 14, 2020

BUY
$5.17 - $8.91 $710,399 - $1.22 Million
137,408 Added 164.26%
221,059 $1.84 Million
Q3 2019

Nov 14, 2019

BUY
$7.38 - $12.25 $77,490 - $128,625
10,500 Added 14.35%
83,651 $617,000
Q2 2019

Aug 13, 2019

BUY
$9.35 - $11.41 $21,972 - $26,813
2,350 Added 3.32%
73,151 $821,000
Q1 2019

May 14, 2019

BUY
$9.5 - $19.16 $375,250 - $756,820
39,500 Added 126.19%
70,801 $761,000
Q3 2018

Nov 14, 2018

SELL
$18.04 - $26.41 $55,563 - $81,342
-3,080 Reduced 8.96%
31,301 $579,000
Q2 2018

Aug 14, 2018

BUY
$21.38 - $29.68 $230,476 - $319,950
10,780 Added 45.68%
34,381 $786,000
Q1 2018

May 15, 2018

SELL
$21.76 - $34.22 $176,256 - $277,182
-8,100 Reduced 25.55%
23,601 $671,000
Q4 2017

Feb 13, 2018

BUY
$19.0 - $23.09 $369,569 - $449,123
19,451 Added 158.78%
31,701 $669,000
Q3 2017

Nov 14, 2017

BUY
$13.53 - $18.17 $165,742 - $222,582
12,250
12,250 $223,000

Others Institutions Holding CTMX

About CytomX Therapeutics, Inc.


  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $66M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.